Passionate about making a profound impact on patients’ lives
Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic clinical candidates capable of improving the lives of millions living with chronic hepatitis B virus (HBV) infection around the world, and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including HBV, hepatitis delta virus (HDV) and herpesviruses.
Focused on Transforming Treatment of Serious Viral Diseases
Assembly Bio’s team aspires to advance treatment options for patients through the discovery and development of novel antivirals. We aim to deliver finite and curative therapies for HBV, one of the world’s most prevalent and devastating infectious diseases, and to progress differentiated research programs directed at serious viral diseases.
Board of Directors
Chairman of the Board, Non-Executive
President & Chief Executive Officer, Director
Scientific Advisory Board
331 Oyster Point Blvd.
South San Francisco, CA 94080